Unless otherwise noted, all growth rates in this Release refer to same period in prior year.    2. Please see detailed guidance assumptions on page 7.    3. USD millions unless indicated otherwise.

Second-quarter net sales rose 1% at constant currency as growth from some of its top-selling products offset declines for ...

Novartis saw its sales grow 3% in the second quarter, returning to growth after a 1% fall in the first quarter caused by ...

Novartis said it returned to sales growth for the second quarter, after lower-priced competition in the U.S. for drugs that went off patent weighed on its top and bottom lines in prior quarters. Net ...

Although the revenue and EPS for Novartis (NVS) give a sense of how its business performed in the quarter ended June 2026, it ...